Abstract: Effects of the automated in ovo injection of stimulant solutions (200 µL) on growth and yolk utilization in the broiler embryo was investigated in 3 trials. Treatment solutions were injected into the amnion of embryos on d 16 of incubation. Treatment effects on 0 to 18 d percentage incubational egg weight loss, proportional embryo BW, proportional yolk sac weight and embryo and yolk sac moisture contents on d 18 were determined. In trial 1, 1 mM caffeine decreased proportional embryo BW and increased percentage embryo mortality and moisture content. At 1 x 10 and 10 mM concentrations, caffeine decreased -3 -6
INTRODUCTION
Broiler breeder eggs contain an excess of fat and moisture, whereas available protein and carbohydrate stores may be limited (Al-Murrani, 1978; Ohta et al., 1999; Uni et al., 2005) . However, despite the fact that embryogenesis requires increased amounts of energy, particularly late in incubation, not all yolk fat can be efficiently utilized (Zhai et al., 2008) . On day of hatch, approximately one fourth of initial yolk stores remain unabsorbed by chicks. Glycogen can be synthesized from fat or protein and stored in the liver of embryos as a supply of glucose for hatching; however, the in ovo injection of external nutrients such as amino acids (Ohta et al., 1999; Kadam et al., 2008) , carbohydrates (Tako et al., 2004) and vitamins (Gore and Qureshi, 1997) , has been shown to promote post-hatch growth and BW gain in birds. Caffeine, the active ingredient in coffee, is the world's best known stimulant. It serves as both a metabolic and central nervous system stimulator (Voet and Voet, 2004) . Theophylline is the main active ingredient in tea and also an active metabolic product of caffeine catabolism (Siegel et al., 1999) . There are certain cell types that respond better to theophylline than caffeine and as such each form may cause a distinctive response in different cells (Devlin, 1997) . However, caffeine may provide more sustained stimulation effects than theophylline (Fang et al., 1998) . Consumption of caffeine may stimulate the mobilization of fatty acids from adipose tissue and increase the level of circulating fatty acids in the blood, which permits these fat stores to be oxidized to produce energy (Graham et al., 2008) . Furthermore, caffeine is known to increase the utilization of exogenous carbohydrate in humans undergoing exercise by a s much as 26% (Yeo et al., 2005) . Creatine and phosphocreatine are important compounds in the normal energy metabolism of muscle and the creatine/phosphocreatine system works as a buffer when adenosine triphosphate concentrations become elevated (Clark, 1997) . Phosphocreatine is a high energy storage compound found in many different cells (Devlin, 1997; Voet and Voet, 2004) and may serve as a phosphate reservoir, thereby reducing the need for adenosine triphosphate as a source by which to load creatine with phosphate. The consumption of creatine can improve intramuscular phosphocreatine concentrations and increased phosphocreatine concentrations increase muscle cell volume, which subsequently triggers additional protein and glycogen synthesis in association with a reduction in protein breakdown (Haussinger, 1996; Ziegenfuss et al., 2002) .
theophylline, creatine and phosphocreatine were tested. Dietary creatine supplementation has been shown to In trial 3, 1.0 mM concentrations of theophylline, creatine improve feed efficiency in chickens (Stahl et al., 2003) .
and L-arginine were used in conjunction with 5.5 mM However, because phosphocreatine itself is an energy KCl (Fisher Scientific, San Jose, CA). source, it may be more useful than creatine i n stimulating yolk utilization during incubation and Injection procedure: Injections were performed using subsequently reducing yolk wastage.
an IntelliLab single egg injector (AviTech, LLC, Salisbury, Although glucose is important in electrolyte solutions as MD). Eggs were injected through the air cell with a blunt an electrolyte balancer and as a means by which to tip injector needle [18.4-cm length and 1.27-mm bore increase water absorption (Snyder, 1991; Rehrer, 2001), width (o.d.) ] to target the amnion. The needle provided amino acids have proven useful in the place of glucose an approximate 2.49 cm injection depth from the top of in some tested electrolyte solutions (Lima et al., 2002) .
the large end of the egg (Keralapurath et al., 2010) . L-arginine acts as an inducer of lipolytic hormones Injection volumes of 200 µL were used in all 3 trials. The (Kalkhoff et al., 1973) and is also a known glycolytic standard error for injection volume was 0.1 %. To ensure amino acid (Devlin, 1997; Voet and Voet, 2004) . Lthat the material was being delivered into the amnion, a arginine has been further evaluated for its potential as a validation test was performed using a water soluble dye glycolytic amino acid and has proven effective as such in that w as injected on d 16 of incubation. The test turkeys (Foye et al., 2006) . confirmed that the solution was being correctly injected It is proposed that the in ovo injection of the above into the amnion. On d 16 of incubation in trials 1, 2 and stimulants may increase metabolic activity by increasing 3, eggs were weighed and randomly assigned to an nutrient availability in the egg and subsequently promote injection treatment group prior to injection. In order to the growth of embryos. The objective of this study was to avoid subsequent contamination and treatment solution determine which of these stimulants and their crossover, the injector was equipped with an automated combinations used for in ovo injection might stimulate cleaning cycle after the injection of each individual egg embryo metabolism and promote embryo yolk nutrient and on each tray, all eggs belonging to a particular utilization and subsequent growth.
treatment were injected with their corresponding
MATERIALS AND METHODS

Incubation:
The current experimental protocol was approved by the Institutional Animal Care and Use Committee of Mississippi State University. Broiler hatching eggs (Ross x Ross 308) were obtained from flocks from a commercial source that were between 35 and 54 wk of age. However, all the eggs used within a trial were collected from a common flock at the same age. All eggs were held for 3 to 4 d under standard storage conditions prior to setting. Eggs were weighed individually and were arranged randomly in each of 4 incubator trays in trial 1 and in 2 incubator trays in trials 2 and 3, in a Jamesway AVN single stage incubator. All treatment groups were represented on each tray and the total number of eggs set in each treatment group among all trays in trials 1, 2 and 3, were 20, 10 and 20, respectively. Incubator dry and wet bulb temperatures were set at 37.6±0.1 C and 29.0±1.0 C, respectively. . Eggs containing early were performed to achieve lower concentrations at 1 x dead embryos were recorded for calculation of post-10 , 1 x 10 and 1 x 10 mM. In trial 2, 1 mM solutions of injection mortality percentage in trial 1.
-3 -6 -9
solution before switching to another treatment. The eggs were placed back into the incubator on their corresponding tray after eggs in all treatment groups were injected. All eggs were held outside the incubator less than 5 min while injecting. (Muther, 1988; Nolm, 1988; Golding, 1995) . PEMBW, PYSW, PYSMOI and PEMBMOI. Individual tray
In the current study, even though the lower was considered as a replicate unit, with the number of concentrations of caffeine that were injected (1 x 10 , 1 replicate units sufficient for embryonic mortality data x 10 , or 1 x 10 mM) did not cause embryonic death, analysis in trial 1. A one-way ANOVA was used to test for they retarded growth. In trial 1, the in ovo injection of the effects of treatment with treatment designated as a caffeine at 1, 1 x 10 and 1 x 10 mM concentrations fixed effect and tray as a random effect. The MIXED decreased PEMBW and caffeine at 1 and 1 x 10 mM procedure of SAS software (SAS Institute, 2003) was concentrations increased PEMBMOI (Table 1) . During used in all data analysis. Fisher's protected LSD (least late embryogenesis, lipid concentrations increase in the significant difference) test was used to compare means bodies of broiler embryos (Peebles et al., 1999) . The (Steel and Torrie, 1980) . Comparisons between means most extensive catabolism of lipids begins on d 15 of were made when there were significant global effects, incubation and contributes approximately 7.5% of the with all differences considered significant at p<0.05.
total water content of the egg in the form of metabolic
RESULTS AND DISCUSSION
In all the trials of this study, there were no differences in SEW among all treatment groups, which would eliminate SEW as a possible confounding factor on the parameters investigated. In trial 1, caffeine at a 1 x 10 , -3 1 x 10 , or 1 x 10 mM concentration had no detrimental -6 -9
effect on embryo mortality. There were no significant differences between the control treatments and the 1 x 10 , 1 x 10 , or 1 x 10 mM caffeine injected treatments.
However, embryonic mortality in the 1 mM caffeine injection group was higher (p<0.01) than that in the noninjected control and the 117 mM saline injection control groups. Mean mortality in the non-injected control, 117 mM saline and 1, 1 x 10 , 1 x 10 and 1 x 10 mM -3 -6 -9
caffeine treatments were 0, 0, 25.0, 5.0, 15.0 and 11.3%, respectively (SEM = 4.44). It has been shown in a previous study by Lee et al. (1982) that caffeine caused neural tube defects and inhibited morphogenesis o f nearly all primordial organs in early chick embryos. The effects of caffeine have further been shown to b e concentration dependent (Lee et al., 1982) . This study has confirmed that the effects of caffeine in selected commercial broiler embryos is also concentration dependent and more specially that survivability i s reduced when caffeine is administrated at a 1 m M concentration on d 16 of incubation. Caffeine has been water (Romanoff and Romanoff, 1967; Simkiss, 1980; Berg et al., 2002) . Caffeine stimulates fatty acid oxidation, which produces water as a metabolic byproduct (Acheson et al., 1980) . The increase i n PEMBMOI in response to the injection of 1 and 1 x 10 -6 mM caffeine, therefore, may be a result of its stimulation of lipid hydrolysis. However, a similar PYSW among all treatments would also indicate that the injection o f caffeine did not accelerate yolk absorption or yolk utilization in the embryos. Therefore, it is suggested that the increase in PEMBMOI was a result of an increase in the oxidation of body fat rather than yolk fat. A similar PYSMOI among all treatments would also suggest that the water in the embryonic tissues produced as a metabolic by-product was not subsequently transferred to the yolk sac. This is supported by the finding of Simkiss (1980) that water movement towards the embryo occurs at a rate that is 4 to 5 times higher than that of the reverse flux. Because 1 mM caffeine caused an elevated rate of mortality in trial 1, the effects of caffeine were not tested again in trial 2. Instead, 1 mM theophylline, a metabolite of caffeine, was used in trial 2. In a previous study conducted in our laboratory (McGruder et al., 2011) , it was shown that KCl was superior to NaCl for use as an electrolyte in solutions prepared for in ovo injection. In trial 3, theophylline, creatine, or L-arginine were tested in combination with 5.5 mM KCl. Creatine rather than phosphocreatine and L-arginine at the concentrations phosphocreatine was used in trial 3, because creatine tested in this study, apparently did not cause a sufficient was more available and was less expensive than change in the energy metabolism of the embryos so as phosphocreatine and the effects of creatine in trial 2 to affect their development. Although the aforementioned were not different from those of phosphocreatine.
parameters were not significantly affected by treatment, However, no evidence was found that all stimulants that the treatment means for the parameters investigated in were tested individually in trial 2 or in combination with trials 2 and 3 are presented in Tables 2 and 3 , KCl i n trial 3 had detrimental effects. All of these respectively, for observation. stimulants did not affect any parameters examined. To
The results of the current study suggest that except for 1 some degree, embryos have the ability to regulate their mM caffeine, at the concentrations used for amniotic development based on the availability of nutrients under injection, the stimulants tested were compatible t o various conditions (Simkiss, 1980) . The creatine/ embryogenesis. However, it is apparent that embryonic phosphocreatine system activates glycogenolysis and metabolic changes, such as the observed decrease in glycolysis by liberating phosphate. This in turn integrates PEMBW and the increase in PEMBMOI elicited by the phosphocreatine and carbohydrate degradation for the lower concentration of caffeine (1 x 10 mM), can occur maintenance of ATP levels necessary for skeletal without negatively affecting embryo survivability. Further muscle development. Conversely, high levels o f research should be conducted to determine how the fat, phosphocreatine can reduce ADP-stimulated protein and carbohydrate concentration profiles o f mitochondrial respiration (Greenhaff, 2001; Walsh et al., embryonic and post-hatch chick body tissues might be 2001). Carbohydrates are preferentially used instead of affected by the injection of stimulants. Moreover, fat to meet energy demands, particularly when excess because the embryo may use external nutrients to meet carbohydrates are available. However, in order to satisfy its energy needs, thereby preserving its own nutrients for this demand, fat utilization may be accelerated when growth, different developmental responses may result carbohydrates are unavailable. Exogenous stimulants when external nutrients are injected into growing can accelerate carbohydrate and fat oxidation for the embryos together with these stimulants. In conclusion, production of energy; however, via negative feed-back the combined results of these current aforementioned inhibition, the accumulation of adenosine triphosphate trials confirm that the tested stimulants, within certain may inhibit the further mobilization of fat and concentration ranges, may be safely used individually or carbohydrates for energy production (Guyton and Hall, in combination with electrolyte solutions for the in ovo 2000; Berg et al., 2002 
